Navigation Links
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Date:3/6/2009

ificant long-term revenue for the Company while building value for our shareholders," said Juergen Engel, Ph.D., President and CEO of AEterna Zentaris.

About the Phase 3 Program with Cetrorelix in BPH

Cetrorelix pamoate is currently in three Phase 3 trials involving more than 1,600 patients with symptomatic BPH in Canada, the United States and Europe.

The first multi-center efficacy study for which patient recruitment was completed in April 2008, is currently being conducted primarily in the United States and Canada, with additional sites in Europe and involves 667 patients under the supervision of lead investigator, Herbert Lepor, MD, Professor at NYU School of Medicine, New York. Patients enter a 4-week run-in no-treatment observation period to confirm severity and stability of voiding symptoms based on the International Prostate Symptom Score (IPSS). Patients are then randomly allocated to cetrorelix or placebo in a double-blind fashion. Patients are administered cetrorelix by intra-muscular (IM) injection at Week 0, 2, 26 and 28 and are followed up to Week 52. Then, in an open-label extension, patients receive cetrorelix by IM injection at Week 52, 54, 78 and 80 and are followed up to Week 90.

The second multi-center Phase 3 efficacy study for which patient recruitment was completed in October 2008, involves 420 patients, mainly in Europe. Patients in this randomized placebo-controlled study with open-label extension conducted under the supervision of lead investigator, Prof. Frans M.J. Debruyne, MD, of the Andros Mannenkliniek, Arnhem, The Netherlands, receive cetrorelix according to similar dosing regimens used in the first study.

The primary endpoint for both North American and European efficacy studies is absolute change in IPSS between baseline and Week 52. Other efficacy endpoints include additional measures of BPH symptom progression and the need for BPH-related surgery. Safety endpoints include ch
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. AEterna Zentaris to Present at Upcoming RBC Capital Markets Healthcare Conference
2. AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
3. AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
4. AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
5. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
6. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
7. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
8. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
9. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
10. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
11. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... CALGARY , June 2, 2015 /CNW/ - Shell today ... fuel in the premium category with an exhibit the ... Square, that included interactive demonstrations for media and the ... New Shell V-Power NiTRO+ Premium Gasoline provides the best ... diminished engine performance: engine wear, gunk and corrosion. ...
(Date:6/2/2015)... 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/6wjpd6/bioburden_testing ... Testing Market by Product , Test, Application & End ... offering. The bioburden testing market is expected ... in 2014, growing at a CAGR of 9.8% from ... the microbial limit testing market is segmented into consumables ...
(Date:6/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/7264hm/biomarkers ) has ... "Biomarkers - Technologies, Markets and Companies" ... the broad definition of a biomarker as a ... as an indicator of normal biological or pathogenic ... therapeutic intervention. Tests based on biomarkers have been ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ... independent blade-based and rackmount computing and storage infrastructure ... the launch of its high density scale-out, two-in-one ... Cirrascale Slipstream™ RM1622D . The high density, two-in-one ... v4 product family with Intel® Iris™ Pro graphics ...
Breaking Biology Technology:New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 4Bioburden Testing Market 2015 - Global Forecasts to 2019 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3
... Jayne Garno, LSU associate professor of chemistry in the ... government,s highest honor for scientists and engineers in the ... Early Career Award for Scientists and Engineers, or PECASE. ... a prestigious award. LSU is a rich environment for ...
... Celsion Corporation (Nasdaq: CLSN ), a late ... heat sensitive liposomal platform to encapsulate and deliver high ... changed  the date and time to discuss third quarter ... November 11, 2010.  The SEC,s EDGAR service will not ...
... Treatment of Spinal Injuries -- SEOUL, South Korea, November 10, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Biology Technology:LSU’s Jayne Garno receives early career award from President 2Celsion Announces Date and Time Change for Third Quarter 2010 Financial Results Conference Call to Monday, November 15, 2010 2Stem Cell Study Shows Benefits in Treatment of Spinal Injuries 2Stem Cell Study Shows Benefits in Treatment of Spinal Injuries 3Stem Cell Study Shows Benefits in Treatment of Spinal Injuries 4Stem Cell Study Shows Benefits in Treatment of Spinal Injuries 5Stem Cell Study Shows Benefits in Treatment of Spinal Injuries 6Stem Cell Study Shows Benefits in Treatment of Spinal Injuries 7
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
(Date:4/27/2015)... Conn. , Apr. 27, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... commence shipping to pre-order customers the first week of ... through the month of May. ... a significant milestone for the company as Wocket® enters ...
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... of the Deepwater Horizon oil well last spring, nearly 2 ... Mexico to contain the spill. While preliminary reports suggest that ... of such a massive volume of dispersant on ecosystems, wildlife ... University at Buffalo researcher with expertise in how the main ...
... digital evolution techniques that give scientists the ability to watch ... light on what it is that makes species altruistic. ... of others, altruism has been a bit of a genetic ... challenges in evolutionary theory. However, a paper published online ...
... release is also available in Chinese on ... -- At its most basic level, understanding chemistry means understanding ... of Chemical Physics not only maps the movement of ... and proton transfer that is quite different from any previously ...
Cached Biology News:A less toxic, more efficient dispersant is scientist's goal 2Research sheds light on altruism 2Research sheds light on altruism 3Watching electrons move in real time 2
...
... a powerful tool for sample purification in ... DNA/RNA or protein purification as well as ... automated on the Genesis Series of instruments ... combination with the RoMa arm and Tecans ...
... filters suitable for use in the Microsart e.motion ... each filter, in a specially designed individual package ... of the band of membrane filter units ensures ... shape of the sealed band guarantees uniform dispensing ...
...
Biology Products: